How to buy Moderna (MRNA) stocks

Learn how to easily invest in Moderna stocks.

Moderna is a biotechnology business based in the US. Moderna shares (MRNA) are listed on the NASDAQ and all prices are listed in US Dollars.

Its last market close was $44.44 – an increase of 0.41% over the previous week. Moderna employs 5,600 staff and has a trailing 12-month revenue of around $5.1 billion.

Our top picks for where to buy Moderna stock

Best for Beginners

Go to site
Easy to use app
  • 100 free trades signup offer
  • Easy-to-use platform
  • Low fees
  • Student and young investor discounts

Best for Lowest Commissions

Go to site
Low margin rates
  • Access to international stock exchanges
  • Low margin rates
  • Powerful research tools

Best for Low Fees

Go to site
CA & US trading
  • 6% cash rebate plus $2,200 in trading perks
  • Low transaction fees
  • Easy-to-use app

How to buy Moderna stock

  1. Choose a stock trading platform. Compare investment platforms.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – MRNA. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Moderna stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product CAFST Available Asset Types Account Types Stock Trading Fee Account Fee Offer
Interactive Brokers
Finder Score: 4.2 / 5: ★★★★★
Interactive Brokers
Stocks, Bonds, Options, Index Funds, ETFs, Currencies, Futures
RRSP, TFSA, Personal, Joint
min $1.00, max 0.5%
$0
CIBC Investor's Edge
Finder Score: 3.7 / 5: ★★★★★
OFFER
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, Precious Metals, IPOs
RRSP, RESP, RRIF, TFSA, Personal, Joint
$6.95
$0 if conditions met, or $100
Get 100 free trades when you open a CIBC Investor’s Edge account using promo code EDGE2425. Plus, get $200 or more cash back. Valid until March 31, 2025.
Moomoo Financial Canada
Finder Score: 3.9 / 5: ★★★★★
CASHBACK
Moomoo Financial Canada
Stocks, Options, ETFs
RRSP, TFSA, Personal
$0.014/stock
$0
Enjoy a 6% cash rebate, plus $2,200 in trading perks.
RBC Direct Investing
Finder Score: 3.8 / 5: ★★★★★
RBC Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, Precious Metals, IPOs
RRSP, RESP, RRIF, TFSA, Personal, Joint, Business
$6.95 - $9.95
$0 if conditions met, otherwise $25/quarter
Questrade
Finder Score: 3.9 / 5: ★★★★★
Questrade
Stocks, Bonds, Options, Mutual Funds, ETFs, Forex, GICs, Precious Metals, IPOs
RRSP, RESP, RRIF, TFSA, Personal
$4.95 - $9.95
$0
Qtrade Direct Investing
Finder Score: 3.6 / 5: ★★★★★
OFFER
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
RRSP, RESP, RRIF, TFSA, Personal, Joint
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Get 1% cashback or more, a $150 sign-up bonus & unlimited free trades until April 30th, 2025.
loading

Moderna stock price (NASDAQ: MRNA)

Use our graph to track the performance of MRNA stocks over time.

Moderna stocks at a glance

Information last updated 2024-12-04.
Latest market close$44.44
52-week range$35.80 - $170.47
50-day moving average $51.96
200-day moving average $94.77
Wall St. target price$76.41
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-5.81

Is it a good time to buy Moderna stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Moderna price performance over time

Historical closes compared with the close of $44.44 from 2024-12-06

1 week (2024-12-02) 0.41%
1 month (2024-11-08) -5.10%
3 months (2024-09-09) -41.99%
6 months (2024-06-07) -70.57%
1 year (2023-12-08) -44.67%
2 years (2022-12-08) -75.94%
3 years (2021-12-08) 283.4
5 years (2019-12-09) 136.63%

Moderna financials

Revenue TTM $5.1 billion
Gross profit TTM $10.6 billion
Return on assets TTM -9.55%
Return on equity TTM -17.52%
Profit margin -43.77%
Book value $30.98
Market Capitalization $16 billion

TTM: trailing 12 months

Moderna stock dividends

We're not expecting Moderna to pay a dividend over the next 12 months.

Moderna stock price volatility

Over the last 12 months, Moderna's stocks have ranged in value from as little as $35.8 up to $170.47. A popular way to gauge a stock's volatility is its "beta."

MRNA.US volatility(beta: 1.69)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Moderna's is 1.69. This would suggest that Moderna's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Moderna overview

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.

Frequently asked questions

What percentage of Moderna is owned by insiders or institutions?
Currently 9.524% of Moderna stocks are held by insiders and 71.58% by institutions.
How many people work for Moderna?
Latest data suggests 5,600 work at Moderna.
When does the fiscal year end for Moderna?
Moderna's fiscal year ends in December.
Where is Moderna based?
Moderna's address is: 200 Technology Square, Cambridge, MA, United States, 02139
What is Moderna's ISIN number?
Moderna's international securities identification number is: US60770K1079
What is Moderna's CUSIP number?
Moderna's Committee on Uniform Securities Identification Procedures number is: 60770K107
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site